Download presentation
Presentation is loading. Please wait.
1
Binge Eating Disorder: 3. Pharmacotherapy
James E Mitchell, M.D. Feel free to re-title and remove Penn specific stuff
2
Pharmacotherapy OF BED
Target BE? Target Weight? Target Both? Target Comorbidity? Target All Three?
3
Disclosure: I was a paid consultant to the pharmaceutical firm that makes LDX in 2016
5
Pharmacotherapy for Binge Eating Disorder
Class Drug Tricyclics eg. Imipramine SSRIs eg. Citalopram SNRIs/NRIs eg. Atomoxetine Lipase Inhibitor Orlistat Amphetamine Pro-drug Lisdexamfetamine Anti-Epileptics eg. Topiramate Other Classes eg. Na Oxybate Combinations eg. Topiramate + Phentermine
6
Class Drug Effect on Binge Eating Effect on Weight Tricyclics Imipramine ++ +/- Desipramine SSRIs Citalopram Escitaloprm Fluvoxamine Sertraline Fluoxetine SNRIs/NRIs Atomoxetine + Venlafaxine Duloxetine
9
Decreased Fat Absorption: An Inventive Vocabulary
Oily spotting Flatus with discharge Fecal urgency Fatty/oily stool Oily evacuation Increased defecation Fecal incontinence Diarrhea
10
Fat-Soluble Vitamins and Carotenoids
Vitamin A Vitamin D Vitamin E Vitamin K (prothrombin time) Beta-carotene
11
Anti-epileptic Medications
and Lisdexamfetamine Medication Effect on Binge Eating Effect on Weight Topiramate ++ Zonisamide Lisdexamfetamine* (*Only FDA approved agent: Indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) in adults)
12
Prior Medications for Obesity
Past Various Amphetamines Sibutramine Fenfluramine/phentermine (Fen/Phen) CB1 antagonists
13
Amphetamines Racemic amphetamine Dextroamphetamine
Introduced in the treatment of narcolepsy by Prinzmetal and Bloomberg in 1935 Dextroamphetamine Introduced for calming hyperexcitable-hyperactive children, by Bradley, in 1937 Also tried in the treatment of depression, but with little success
19
Class Effect on Binge Eating Effect on Weight
Drug Effect on Binge Eating Effect on Weight Other Classes Na Oxybate Inadequate Data Baclofen Lamotrigine Acamprosate
20
Drugs/Combinations with Weight Loss Effects in BED
Topiramate (+ Phentermine or Bupropion) Zonisamide (+ Phentermine or Bupropion) Bupropion (+ Naltrexone) Lisdexamfetamine
21
Drugs/Combinations for Weight Loss in BED with DM
Topiramate (+ Phentermine or Bupropion) Zonisamide (+ Phentermine or Bupropion) Bupropion (+ Naltrexone) Lisdexamfetamine Metformin Incretin (GLP-1) Mimetics DPP-4 Inhibitors (+/-)
22
Phentermine + Topiramate
Synergy for weight loss Lower doses can be used
23
Phentermine + Topiramate
Anorexigenic agent 52 year history of use Most widely prescribed weight loss drug in U.S. Topiramate Anticonvulsant agent
24
Phentermine +Topiramate
Mechanism of Action Phentermine Sympathomimetic amine Topiramate Block neuronal voltage-dependent Na+ channels Antagonize AMPA/kainite glutamate receptors Enhance GABA-A activity
25
Phentermine + Topiramate
Mechanism of weight loss Phentermine appetite reduction Topiramate increased satiety increased energy expenditure
26
Phentermine + Topiramate
Common adverse events in clinical trials Paresthesia Dry mouth Constipation Upper respiratory tract infection Nasopharyngitis Headache
27
Phentermine + Topiramate
Cognitive side effects Disturbance in attention/memory/word finding Poor insight into problem Minimize if start Topiramate at 25 mg, increase by 25 mg/week, maximum 200 mg Cognitive disturbances resolves after drug discontinuation.
28
Bupropion + Naltrexone
Antidepressant with Weight loss effects NE and DA reuptake inhibition Mechanism of decreased appetite involves POMC effects Naltexone Long acting narcotic antagonist Opioid blockade enhances effects at POMC
29
Bupropion + Naltrexone
Side-effects seizure activity dry mouth, nausea headache, dizziness, ringing in ears vision changes sore throat muscle pain nausea, vomiting stomach pain or cramping. nervousness irritability .
30
Lisdexamfetamine (LDX)
Red Blood Cells
33
LDX Side-effects Decreased appetite Headache Irritability Insomnia
Not to be used with substance abuse history
35
Questions/Comments?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.